《美股業績》美光上季多賺1.75倍勝預期 料晶片短缺明年緩解
美光科技(MU.US)首財季非通用會計準則(Non-GAAP)盈利按年增長1.75倍至24.71億美元,調整後每股盈利爲2.16美元,超出預期的每股2.11美元。收入則增長33%至76.9億美元,高於預期的76.7億美元,受惠於數據中心及電動車晶片的需求強勁。
美光還透露已與供應商達成協議,以解決供應鏈樽頸問題,相信明年晶片短缺問題可有所緩解。美光預計第二財季收入爲75億美元,上下浮動2億美元,分析師平均估計爲72.7億美元。公司又預計調整後每股盈利爲1.95美元,上下浮動0.1美元,超過預期的1.86美元。
在業績公佈後,美光股價於盤後上升6.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.